Skip to main content
. 2021 Mar 19;58(7):919–927. doi: 10.1007/s00592-021-01700-2

Fig. 7.

Fig. 7

The figure depicts the main results of the pilot study. The group wearing the Telemedicine device demonstrated a significantly lower glycosylated hemoglobin with respect to the control group